Davide Tassinari

5.9k total citations
144 papers, 2.8k citations indexed

About

Davide Tassinari is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Davide Tassinari has authored 144 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 44 papers in Pulmonary and Respiratory Medicine and 22 papers in Surgery. Recurrent topics in Davide Tassinari's work include Colorectal Cancer Treatments and Studies (18 papers), Lung Cancer Treatments and Mutations (12 papers) and Palliative Care and End-of-Life Issues (11 papers). Davide Tassinari is often cited by papers focused on Colorectal Cancer Treatments and Studies (18 papers), Lung Cancer Treatments and Mutations (12 papers) and Palliative Care and End-of-Life Issues (11 papers). Davide Tassinari collaborates with scholars based in Italy, Germany and United Kingdom. Davide Tassinari's co-authors include Sergio Sartori, Vincenzo Abbasciano, Ingrid Nielsen, M. Zachmann, A. Prader, E Cacciari, Paola Tombesi, Lucio Trevisani, Marco Maltoni and Emanuela Scarpi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Davide Tassinari

141 papers receiving 2.7k citations

Peers

Countries citing papers authored by Davide Tassinari

Since Specialization

Citations

This map shows the geographic impact of Davide Tassinari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Tassinari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Tassinari more than expected).

Fields of papers citing papers by Davide Tassinari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Tassinari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Tassinari. The network helps show where Davide Tassinari may publish in the future.

Co-authorship network of co-authors of Davide Tassinari

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Tassinari. A scholar is included among the top collaborators of Davide Tassinari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Tassinari. Davide Tassinari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of Oocyte Extract Supplement on Quality of Life after Hepatectomy for Liver Tumours: A Prospective, Multicentre, Double-Blind Randomized Clinical Trial 2023 ·Cancers ·Matteo Donadon, Angela Palmisano, Mariano Bizzarri, Roberto Ceriani, (unknown), (unknown), Davide Tassinari, Massimo Viola, Emiliano Tamburini, Guido Torzilli	1
2	P2.01-15 Phase II Single Arm Study of CABozantinib in Non-Small Cell Lung Cancer Patients with MET Deregulation (CABinMET) 2019 ·Journal of Thoracic Oncology ·M. D’Arcangelo, Davide Tassinari, Filippo de Marinis, Angelo Delmonte, Domenico Galetta, Fabiana Letizia Cecere, Sara Pilotto, Francesca Zanelli, Laura Bonanno, Lorenza Landi, Federica D’Incà, Federico Cappuzzo	9
3	Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trial 2018 ·OncoTargets and Therapy ·Andrea Casadei‐Gardini, Emanuela Scarpi, Elena Orlandi, Davide Tassinari, Silvana Leo, Ilaria Bernardini, Fabio Gelsomino, Stefano Tamberi, Silvia Ruscelli, Roberto Vespignani, Sonia Ronconi, Giovanni Luca Frassineti, Dino Amadori, Alessandro Passardi	10
4	Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study 2017 ·Scientific Reports ·Andrea Casadei‐Gardini, Flavia Foca, Mario Scartozzi, Nicola Silvestris, Emiliano Tamburini, Luca Faloppi, Oronzo Brunetti, (unknown), Salvatore Pisconti, Martina Valgiusti, Giorgia Marisi, Francesco Giuseppe Foschi, Giorgio Ercolani, Davide Tassinari, Stefano Cascinu, Giovanni Luca Frassineti	28
5	Treatment beyond progression in patients with advanced RCC participating in the expanded access programme (EAP) 2017 ·Annals of Oncology ·Enrico Cortesi, Federico Cappuzzo, Luca Galli, Alessandra Bearz, Sandro Pignata, Alfredo Berruti, Giampaolo Tortora, Davide Tassinari, Stefano Panni, Antonio Pazzola, Giammarco Surico, Michele Maio, Luciano Latini, Giovanni Schinzari, (unknown), (unknown), Francesco Cognetti, Ugo De Giorgi, (unknown), Umberto Basso	4
6	Efficacy and safety data from patients with advanced squamous NSCLC and brain metastases participating in the nivolumab Expanded Access Programme (EAP) in Italy 2016 ·Annals of Oncology ·Paolo Bidoli, Rita Chiari, Annamaria Catino, Francesco Grossi, Cristina Noberasco, Francesco Gelsomino, (unknown), Claudia Proto, Héctor Soto Parrà, M.R. Migliorino, Lucia Bonomi, Davide Tassinari, Antonio Frassoldati, Valeria Albanese, Giovanni Maria Fadda, Francesco Cognetti, Federica De Galitiis, Giovanna Finocchiaro, Angelo Delmonte	18
7	Cisplatin-raltitrexed vs cisplatin-pemetrexed in the treatment of advanced pleural mesothelioma. final results of a network meta-analysis 2016 ·Annals of Oncology ·(unknown), (unknown), Maximilian Papi, Emiliano Tamburini, (unknown), Marino Nicolini, (unknown), (unknown), Lorenzo Gianni, (unknown), Davide Tassinari	1
8	Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer 2015 ·PLoS ONE ·Alessandro Passardi, Emanuela Scarpi, Stefano Tamberi, Luigi Cavanna, Davide Tassinari, Annalisa Fontana, Sara Pini, Ilaria Bernardini, Caterina Accettura, Paola Ulivi, Giovanni Luca Frassineti, Dino Amadori	35
9	Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial 2015 ·Annals of Oncology ·Alessandro Passardi, Oriana Nanni, Davide Tassinari, D. Turci, Luigi Cavanna, Annalisa Fontana, Silvia Ruscelli, Claudia Mucciarini, Vito Lorusso, Angela Ragazzini, Giovanni Luca Frassineti, D. Amadori	121
10	Early Palliative Care in Advanced Oncologic and Non-Oncologic Chronic Diseases: A Systematic Review of Literature 2015 ·Reviews on Recent Clinical Trials ·Davide Tassinari, Fabrizio Drudi, (unknown), Lucia Stocchi, (unknown), (unknown), Emiliano Tamburini, Sergio Sartori	27
11	Cerebral Ischemic Involvement in Vogt-Koyanagi-Harada Disease 2014 ·Pediatric Neurology ·(unknown), Duccio Maria Cordelli, Angela Miniaci, Davide Tassinari, Luca Spinardi, Andrea Pession, Emilio Franzonı	2
12	Il dolore neuropatico in oncologia. Nuove evidenze per la pratica clinica 2011 ·Recenti Progressi in Medicina ·Davide Tassinari, Fabrizio Drudi, (unknown), (unknown), (unknown), (unknown)	2
13	Second-line treatments of advanced non-small-cell lung cancer: new evidence for clinical practice 2009 ·Annals of Oncology ·Davide Tassinari, Fabrizio Drudi, (unknown), Paola Tombesi, Sergio Sartori	7
14	A case of furuncular myiasis associated with systemic inflammation 2007 ·Parasitology International ·Stefania Varani, Davide Tassinari, Daniela Elleri, Sara Forti, Filippo Bernardi, Mario Lima, Stefano Tursini, Vittorio Sambri, Domenico Otranto	11
15	A validation study of the WHO analgesic ladder: a two-step vs three-step strategy 2005 ·Supportive Care in Cancer ·Marco Maltoni, Emanuela Scarpi, (unknown), Alessandro Passardi, Sebastiano Calpona, Adriana Turriziani, (unknown), Davide Tassinari, (unknown), (unknown), Luigi Montanari, (unknown), Dino Amadori	92
16	Sonographically Guided Small-Bore Chest Tubes and Sonographic Monitoring for Rapid Sclerotherapy of Recurrent Malignant Pleural Effusions 2004 ·Journal of Ultrasound in Medicine ·Sergio Sartori, Paola Tombesi, Davide Tassinari, Piercarlo Ceccotti, Ingrid Nielsen, Lucio Trevisani, Vincenzo Abbasciano	18
17	Reply: Prediction of survival in terminally ill cancer patients: why we cannot avoid anevidence-based palliative medicine 2002 ·Annals of Oncology ·Davide Tassinari, Marco Maltoni, D. Amadori	1
18	Breast cancer: Staging of breast cancer: recommended standards 2000 ·Annals of Oncology ·Alberto Ravaioli, Davide Tassinari	3
19	Hemolytic-Uremic Syndrome during Therapy with Estramustine Phosphate for Advanced Prostatic Cancer 1999 ·Oncology ·Davide Tassinari, Sergio Sartori, Ilaria Panzini, (unknown), (unknown)	3
20	How many cases of true precocious puberty in girls are idiopathic? 1983 ·The Journal of Pediatrics ·E Cacciari, (unknown), Alessandro Cicognani, Piero Pirazzoli, Giorgio Frank, Antonio Balsamo, Davide Tassinari, F Zappulla, Roberto Bergamaschi, (unknown)	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact